
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
RECENT PHARMACOLOGY THERAPY FOR HYPERTENSION IN PREGNANCY
Dinesh Kawade*, Payal Bahadurkar, Nikhil Shahu, Payal Hiradewe and Nidhi Dhote
Abstract Hypertensive issue speak to significant reasons for pregnancy related maternal mortality around the world. Like the non-pregnant populace, hypertension is the most widely recognized clinical issue experienced during pregnancy and is evaluated to happen in around 6–8% of pregnancies. There has been for all intents and purposes no change for three decades in the treatment of hypertension in pregnancy and it's numerous namesakes: Pre-eclampsia, gestational hypertension, superimposed pre-eclampsia, gestosis, and so on. The ideal planning and decision of treatment for hypertensive pregnancy issue includes cautiously gauging the hazard versus-advantage proportion for every individual patient, with a general objective of improving maternal and fetal results. Right now have thoroughly analyzed the suggestions in various treatment rules and we have sketched out some more up to date points of view on the board. We have meant to give a clinically orientated manual for the medication treatment of hypertension in pregnancy. Keywords: Hypertension, Pregenancy, Pre-eclampsia, Pharmacotherapy, Management. [Full Text Article] [Download Certificate] |
